Rachel M J van der Velden, Nikki A H A Pluymaekers, Elton A M P Dudink, Justin G L M Luermans, Joan G Meeder, Wilfred F Heesen, Timo Lenderink, Jos W M G Widdershoven, Jeroen J J Bucx, Michiel Rienstra, Otto Kamp, Jurren M van Opstal, Charles J H J Kirchhof, Vincent F van Dijk, Henk P Swart, Marco Alings, Isabelle C Van Gelder, Harry J G M Crijns, Dominik Linz
BACKGROUND: In the Rate Control versus Electrical Cardioversion Trial 7-Acute Cardioversion versus Wait and See, patients with recent-onset atrial fibrillation (AF) were randomized to either early or delayed cardioversion. AIM: This prespecified sub-analysis aimed to evaluate heart rate during AF recurrences after an emergency department (ED) visit identified by an electrocardiogram (ECG)-based handheld device. METHODS: After the ED visit, included patients (n = 437) were asked to use an ECG-based handheld device to monitor for recurrences during the 4-week follow-up period...
January 2024: Clinical Cardiology